Literature DB >> 7494186

Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs.

T Sakane1, M Akizuki, Y Taki, S Yamashita, H Sezaki, T Nadai.   

Abstract

To clarify the relationship between the direct transport from the rat nasal cavity to the cerebrospinal fluid (CSF) and the molecular weight of the drug, the transport of fluorescein isothiocyanate-labelled dextran (FD) with various molecular weights was investigated. FDs (average molecular weights 4,400 (FD4); 9,400 (FD10); 18,900 (FD20); 40,500 Da (FD40)) were administered nasally or intravenously to rats, and the concentrations in the plasma and the CSF were measured and compared. None of the FDs were detected in the CSF after intravenous administration. However, FD4, FD10 and FD20 were observed to appear in the CSF after nasal administration, whereas the concentration in the plasma was much lower than that after intravenous administration. FD40 was not detected even after nasal administration. In addition, the concentration of these FDs in the CSF decreased with the increase in the molecular weight of FDs. These findings show that drugs with a molecular weight up to at least 20,000 Da can be directly transported from the nasal cavity to the CSF and that the transport of FDs to the CSF is dependent on their molecular weights.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494186     DOI: 10.1111/j.2042-7158.1995.tb05814.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  19 in total

1.  Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration.

Authors:  Jeffrey J Lochhead; Daniel J Wolak; Michelle E Pizzo; Robert G Thorne
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

Review 2.  Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.

Authors:  Niyanta N Kumar; Michelle E Pizzo; Geetika Nehra; Brynna Wilken-Resman; Sam Boroumand; Robert G Thorne
Journal:  Bioconjug Chem       Date:  2018-10-24       Impact factor: 4.774

Review 3.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Insoluble powder formulation as an effective nasal drug delivery system.

Authors:  Fusashi Ishikawa; Mika Murano; Minoru Hiraishi; Toshikazu Yamaguchi; Ikumi Tamai; Akira Tsuji
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

5.  Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.

Authors:  Stuart T Charlton; Joanne Whetstone; Susan T Fayinka; Kevin D Read; Lisbeth Illum; Stanley S Davis
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200

6.  Targeted brain delivery of 17 beta-estradiol via nasally administered water soluble prodrugs.

Authors:  Abeer M Al-Ghananeem; Ashraf A Traboulsi; Lewis W Dittert; Anwar A Hussain
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

7.  Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke.

Authors:  Kristian P Doyle; Tao Yang; Nikola S Lessov; Thomas M Ciesielski; Susan L Stevens; Roger P Simon; Jeffrey S King; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2008-03-26       Impact factor: 6.200

8.  Nanotechnology for CNS delivery of bio-therapeutic agents.

Authors:  Lipa Shah; Sunita Yadav; Mansoor Amiji
Journal:  Drug Deliv Transl Res       Date:  2013-08-01       Impact factor: 4.617

9.  Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery.

Authors:  Niyanta N Kumar; Jeffrey J Lochhead; Michelle E Pizzo; Geetika Nehra; Sam Boroumand; Gretchen Greene; Robert G Thorne
Journal:  J Control Release       Date:  2018-08-04       Impact factor: 9.776

10.  Strategies for enhanced drug delivery to the central nervous system.

Authors:  V S N M Dwibhashyam; A N Nagappa
Journal:  Indian J Pharm Sci       Date:  2008 Mar-Apr       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.